Related Experiment Video
Updated: Mar 18, 2026

Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
Comparisons of outcomes with food immunotherapy strategies: efficacy, dosing, adverse effects, and tolerance
Noriyuki Yanagida1, Sakura Sato, Tomoyuki Asaumi
1aDepartment of PediatricsbDepartment of Allergy, Clinical Research Center for Allergology and Rheumatology, Sagamihara National Hospital, Kanagawa, Japan.
Purpose Of Review:
In the recent decade, oral immunotherapy has been studied in many clinical trials and entails many problems including a low efficacy for real tolerance and a high rate of induced symptoms. The optimal dose for inducing tolerance is unknown. The aim of this review was to clarify the efficacy and safety of oral immunotherapy, focusing on low doses.
Recent Findings:
We reviewed articles published in a few years or articles dealing with oral immunotherapy focusing on a low dose. We summarize recent articles on oral immunotherapy and those focusing on low doses.
Summary:
Although lower doses for oral immunotherapy appear to cause fewer adverse reactions and be more effective than strict elimination, this strategy may be less effective than oral immunotherapy involving larger doses. The optimal dose for inducing tolerance is still unknown.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Taste Buds and Receptors
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Bioavailability Study Design: Healthy Subjects Versus Patients
Dose-Response Relationship: Potency and Efficacy
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

